top of page

About Us

Who we are

Caren Pharma develops hormone-based therapeutics for age-related diseases. We reformulate clinically validated agents into novel treatments that target the biological drivers of cognitive decline. Our lead program combines two FDA-approved drugs, repurposed to address age-related memory loss with the goal of reaching patients faster and more effectively.

abstract_background_with_a_network_communications_design_0202.jpg
5.jpeg

(1)

58M+

95% of Americans aged 65+ have a chronic condition

#1

Aging is greatest risk factor for neurodegenerative diseases

(2)

(3)

26%

Increased Alzheimer's risk per 10-point drop in Free T

1. National Council on Aging. Get the facts on healthy aging. National Council on Aging; 2024. Link.​

2. Alzheimer's Association. 2024 Alzheimer's Disease Facts and Figures. Chicago, IL: Alzheimer's Association; 2024. Link.​

3. Moffat et al., Neurology; 2004. Link.​

Our Team

DF Linkedin Headshot 2024.jpg

David Friedman

Chief Executive Officer

Co-Founder

6(1).png

Edward Friedman, PhD

Chief Scientific Officer

Co-Founder

Supported by a broad network of advisors, clinicians, professors, and industry professionals

who share our vision and provide strategic guidance

Strategic Partners

P2.png
P3.png
17.png

Our

S

T

R

Y

O

Abstract Crystal Burst
0.png
Sep
2024

New IP Milestone

close-up-laboratory-microscope-with-set-test-tubes-with-blue-liquid.jpg
Aug
2024

Proof-of-Concept Study

Notebook and Pen
Mar
2005

Dr. Friedman

began publishing

freepik__plain-suitable-background__76431.png
Jun
2013

Dr. Friedman's Book Published

scientist-with-rat-chemical-laboratory-closeup-animal-testing.jpg
Mar
2023

Preclinical Dosing Study

Chicago
May
2019

Caren Pharma Founded

close-up-graduation-diploma.jpg
Sep
2020

IP Licensed

Partner With Us

Collaboration drives progress. We’re advancing the therapeutic potential of hormones to address age-related disease. Let’s connect and explore how we can work together.

bottom of page